Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Some Think GLP-1s Could Be The Next Treatments For Alzheimer’s. So Far, Drug Trial Results Are A Mixed Bag

Summary by IFLScience
Recent trials of two GLP-1s, semaglutide and liraglutide, reported very different results in Alzheimer’s disease patients.

1 Articles

IFLScienceIFLScience
Lean Left

Some Think GLP-1s Could Be The Next Treatments For Alzheimer’s. So Far, Drug Trial Results Are A Mixed Bag

Recent trials of two GLP-1s, semaglutide and liraglutide, reported very different results in Alzheimer’s disease patients.

·Sudbury, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

IFLScience broke the news in Sudbury, United Kingdom on Tuesday, August 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Science icon

Science

GLP-1 icon

GLP-1

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal